-
1Academic Journal
Συγγραφείς: D. V. Khorolsky, A. A. Klimenko, E. S. Pershina, N. M. Babadeva, A. A. Kondrashov, N. A. Shostak, E. P. Mikheeva, E. V. Zhilyaev, Д. В. Хорольский, А. А. Клименко, Е. С. Першина, Н. М. Бабадаева, А. А. Кондрашов, Н. А. Шостак, Е. П. Михеева, Е. В. Жиляев
Πηγή: Modern Rheumatology Journal; Том 17, № 4 (2023); 57-63 ; Современная ревматология; Том 17, № 4 (2023); 57-63 ; 2310-158X ; 1996-7012
Θεματικοί όροι: компьютерная томография легких высокого разрешения, interstitial lung disease, six-minute walk test, autoantibodies, cross-sectional observational study, high-resolution computed tomography of the lungs, интерстициальное заболевание легких, тест с 6-минутной ходьбой, аутоантитела, одномоментное наблюдательное исследование
Περιγραφή αρχείου: application/pdf
Relation: https://mrj.ima-press.net/mrj/article/view/1460/1385; Goh NS, Desai SR, Veeraraghavan S, et al. Interstitial lung disease in systemic sclerosis: a simple staging system. Am J Respir Crit Care Med. 2008 Jun 1;177(11):1248-54. doi:10.1164/rccm.200706-877OC. Epub 2008 Mar 27.; Bergamasco A, Hartmann N, Wallace L, Verpillat P. Epidemiology of systemic sclerosis and systemic sclerosis-associated interstitial lung disease. Clin Epidemiol. 2019 Apr 18; 11:257-273. doi:10.2147/CLEP.S191418. eCollection 2019.; Steele R, Hudson M, Lo E, Baron M; Canadian Scleroderma Research Group. Clinical decision rule to predict the presence of interstitial lung disease in systemic sclerosis. Arthritis Care Res (Hoboken). 2012 Apr; 64(4):519-24. doi:10.1002/acr.21583.; Lumetti F, Barone L, Alfieri C, et al. Quality of life and functional disability in patients with interstitial lung disease related to Systemic Sclerosis. Acta Biomed. 2015 Sep 14; 86(2):142-8.; Zhou Z, Fan Y, Thomason D, et al. Eco-nomic Burden of Illness Among Commercially Insured Patients with Systemic Sclerosis with Interstitial Lung Disease in the USA: A Claims Data Analysis. Adv Ther. 2019 May; 36(5):1100-1113. doi:10.1007/s12325-019-00929-2. Epub 2019 Mar 30.; Tyndall AJ, Bannert B, Vonk M, et al. Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database. Ann Rheum Dis. 2010 Oct;69(10):1809-15. doi:10.1136/ard.2009.114264. Epub 2010 Jun 15.; Aragona CO, Versace AG, Ioppolo C, et al. Emerging Evidence and Treatment Perspectives from Randomized Clinical Trials in Systemic Sclerosis: Focus on Interstitial Lung Disease. Biomedicines. 2022 Feb 21;10(2):504. doi:10.3390/biomedicines10020504.; Van den Hoogen F, Khanna D, Fransen J, et al. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis Rheum. 2013 Nov;65(11):2737-47. doi:10.1002/art.38098. Epub 2013 Oct 3.; Wittram C, Mark EJ, McLoud TC. CT-histologic correlation of the ATS/ERS 2002 classification of idiopathic interstitial pneumonias. Radiographics. 2003 Sep-Oct;23(5): 1057-71. doi:10.1148/rg.235035702.; Suliman YA, Dobrota R, Huscher D, et al. Brief Report: Pulmonary Function Tests: High Rate of False-Negative Results in the Early Detection and Screening of Scleroderma-Related Interstitial Lung Disease. Arthritis Rheumatol. 2015 Dec;67(12):3256-61. doi:10.1002/art.39405.; Rutka K, Garkowski A, Karaszewska K, tebkowska U. Imaging in Diagnosis of Systemic Sclerosis. J Clin Med. 2021 Jan 12;10(2):248. doi:10.3390/jcm10020248.; Ананьева ЛП, Александрова ЕН. Аутоантитела при системной склеродермии: спектр, клинические ассоциации и прогностическое значение. Научно-практическая ревматология. 2016;54(1):86-99.; Yang C, Tang S, Zhu D, et al. Classical Disease-Specific Autoantibodies in Systemic Sclerosis: Clinical Features, Gene Susceptibility, and Disease Stratification. Front Med (Lausanne). 2020 Nov 19;7:587773. doi:10.3389/fmed.2020.587773. eCollection 2020.; Stochmal A, Czuwara J, Trojanowska M, Rudnicka L. Antinuclear Antibodies in Systemic Sclerosis: an Update. Clin Rev Allergy Immunol. 2020 Feb;58(1):40-51. doi:10.1007/s12016-018-8718-8.